Try our Advanced Search for more refined results
Health
-
April 20, 2026
Justices Mull Limits On Federal Review Of State Cases
The U.S. Supreme Court on Monday wrestled with the potential impact of reining in — or even scrapping altogether — a 100-year-old doctrine that curbs litigants' ability to go to federal court to try to overturn a state court loss.
-
April 20, 2026
Inspired Healthcare Creditors Object To Reid Collins Retention
Inspired Healthcare's unsecured creditors have urged a Texas bankruptcy judge to deny the company's bid to retain Reid Collins & Tsai LLP to help investigate the debtor's pre-Chapter 11 conduct, saying that task should fall to unsecured creditors instead.
-
April 20, 2026
'Unserious Leaders Are Unsafe': RFK Jr.'s Trans Edict Voided
An Oregon federal judge struck down Health and Human Services Secretary Robert F. Kennedy Jr.'s efforts to enforce the agency's restrictions on gender-affirming care for minors, finding the restrictions unlawful and criticizing Kennedy's leadership and the policy declaration that introduced the changes.
-
April 20, 2026
GSK, Moderna Both Ordered To Provide More Info In Vax Fight
A special master overseeing discovery disputes in GlaxoSmithKline's infringement suits over Moderna's COVID-19 and related respiratory syncytial virus vaccines ordered both companies to furnish information to each other, including financial data and licenses, according to an opinion unsealed Monday.
-
April 20, 2026
Trump Orders Agencies To Fast-Track Psychedelic Therapies
President Donald Trump on Saturday announced that his administration would instruct federal agencies to accelerate investigations into new therapies derived from psychedelic drugs and streamline patients' access to the treatments.
-
April 20, 2026
Justices Won't Block Multimillion-Dollar Health Fraud Retrial
A man accused of pocketing $12 million as a part of a larger $140 million scheme to defraud public and private healthcare programs can't get out of a second trial, as the U.S. Supreme Court declined to review his case on Monday.
-
April 20, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.
-
April 20, 2026
Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy
Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up to $7 billion.
-
April 20, 2026
3 Firms Advise Blue Owl's $2.4B Tampa Healthcare REIT Buy
Blue Owl Capital agreed to pay $2.4 billion for healthcare-focused real estate investment trust Sila Realty Trust in a take-private deal announced Monday advised by Hogan Lovells, Kirkland & Ellis LLP and Dechert LLP.
-
April 20, 2026
High Court Won't Hear 3rd Circ. J&J Class Cert. Appeal
The U.S. Supreme Court on Monday said it won't review a class certification challenge in a securities class action over Johnson & Johnson's cancer-related talc products in the latest development in a closely watched dispute over how courts evaluate class certification in shareholder suits.
-
April 20, 2026
Justices Won't Consider IP Theft Allegations Against Akin
The U.S. Supreme Court on Monday rejected a former Cornell University graduate student's petition trying to revive his malpractice suit against Akin Gump Strauss Hauer & Feld LLP stemming from patent litigation against Illumina Inc. over DNA sequencing intellectual property.
-
April 17, 2026
ITC Clears Apple's Redesigned Apple Watch For Import
The U.S. International Trade Commission on Friday signed off on an administrative law judge's finding that Apple has sufficiently redesigned its smartwatch so it doesn't infringe Masimo Corp.'s patents and is therefore not bound by a 2023 import ban.
-
April 17, 2026
9th Circ. Revives Doctor's PeaceHealth Whistleblower Suit
A Ninth Circuit panel has reinstated a psychiatrist's claims that PeaceHealth Inc. retaliated against him for expressing concerns about potential Medicaid fraud at a Washington hospital, concluding on Friday that the district court overlooked evidence that the employer punished him by not renewing his employment contract.
-
April 17, 2026
Missed Deadline Fatal To Patient's Stapler Suit, 4th Circ. Says
The Fourth Circuit ruled Friday that a surgery patient's missed expert disclosure deadline rightfully ended his case seeking to hold Johnson & Johnson subsidiary Ethicon Endo-Surgery LLC liable for allegedly faulty staples used in his procedure.
-
April 17, 2026
Federal Judge Blocks DOJ's DEI, Citizenship Grant Conditions
A Rhode Island federal judge has temporarily blocked the U.S. Department of Justice from imposing new conditions related to diversity, equity and inclusion activities and immigration status on domestic violence assistance grants, finding a nonprofit coalition likely to succeed in a legal challenge.
-
April 17, 2026
Plea Change Hearing Set For Former Conn. Budget Official
A change of plea hearing has been scheduled for Monday afternoon for Konstantinos M. Diamantis, a former Connecticut budget official, elected politician and attorney facing an impending federal corruption trial for allegedly pocketing bribes while helping end a state Medicaid audit of an optometry practice operated by his friend's fiancée.
-
April 17, 2026
Connecticut Cardiologist Files $4M Suit Over Alleged Ouster
A Connecticut cardiologist alleges he suffered at least $4 million in damages due to his former practice's "repeated disrespect, bad faith" and reputational damage in the medical community for more than a decade, which culminated in his constructive discharge, filing a contract and defamation lawsuit in state court.
-
April 17, 2026
Judge Says USCIS Can't Keep Delaying Iranians' Work Permits
A California federal judge ordered U.S. Citizenship and Immigration Services to unfreeze its processing of work permit applications for several dozen Iranians and a Sudanese national, finding the agency likely violated federal administrative law by indefinitely delaying decisions.
-
April 17, 2026
Up Next At High Court: SEC And FCC Enforcement Authority
The U.S. Supreme Court's final argument session of this term kicks off Monday, when the justices will consider the U.S. Securities and Exchange Commission's authority to seek disgorgement orders against alleged wrongdoers without proving investors were harmed. Here, Law360 breaks down the week's oral arguments.
-
April 17, 2026
3 Key Questions On Trump's Pharma Tariffs
President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug companies to lower their tariff rates to zero, but questions remain about the requirements for preferential treatment and abilities to administer the regime. Here, Law360 examines three open questions surrounding pharmaceutical tariffs' implementation.
-
April 17, 2026
Verdict For Doctors Affirmed In Fatal E. Coli Infection Appeal
An Illinois appellate panel on Friday affirmed a jury verdict clearing three physicians of liability in a wrongful death suit over a woman's death from septic shock stemming from an undiagnosed E. coli infection, rejecting arguments that evidentiary errors, expert testimony admissions and jury instruction issues warranted a new trial.
-
April 17, 2026
Allstate Says Fla. Surgery Centers Padded Bills For Care
Seven ambulatory surgery centers, a pain clinic and an anesthesia practice that are all run by Surgery Partners conducted "extraordinarily aggressive treatment" on patients involved in minor car crashes to inflate the bills submitted to Allstate, the insurer told a Florida federal court Friday, alleging it paid millions for unnecessary treatment.
-
April 17, 2026
AI Health Co. Illegally Shared Genetic Data, Patients Say
A healthcare company powered by artificial intelligence violated Illinois' genetic privacy law and other consumer protection laws by compelling a genetic testing business it acquired to disclose patients' genetic information, which it then shared through data agreements with pharmaceutical giants such as Eli Lilly and AbbVie, a lawsuit in Illinois federal court says.
-
April 17, 2026
Judge Says Biotech Co. Can't Wipe Cancer Data, For Now
A Texas state judge signed a temporary restraining order on Friday that stops Bellicum Pharmaceuticals Inc. and the consulting firm helping it oversee its dissolution from deleting cell therapy data that the Houston-based MD Anderson Cancer Center says belongs to it.
-
April 17, 2026
Bill Floated To Nix Medical Residency Antitrust Exemption
U.S. Sen. Mike Lee, R-Utah, has introduced legislation to repeal an antitrust exemption given to the medical residency matching program by Congress two decades ago, over concerns about wages and a bottleneck of medical school graduates.
Expert Analysis
-
Del. Blackbaud Ruling Signals A New Era For Cyberinsurance
The recent Delaware Supreme Court ruling in Travelers v. Blackbaud shows that cyberinsurance is moving into a second maturity phase, in which insurers will increasingly attempt to recover their payments from vendors and insureds will face new pressure to justify cyber incident reimbursements, say Steven Teppler at Mandelbaum Barrett and Jade Davis at Shumaker.
-
Opinion
AI Presents A Make-Or-Break Moment For Outside Counsel
The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.
-
DOJ Actions Suggest Expansion Of Healthcare Enforcement
Recent actions by the U.S. Department of Justice and U.S. Food and Drug Administration suggest that federal healthcare enforcement efforts are moving away from traditional program-based fraud and toward cases centered on product integrity, regulatory transparency and telehealth marketing, effectively widening the government's enforcement playbook, say attorneys at MoFo.
-
Series
Watching Hallmark Movies Makes Me A Better Lawyer
I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.
-
New Orphan Drug Law Provides A Key Fix For Pharma Cos.
The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.
-
FDA User Fee Talks Offer Clues On Upcoming Reforms
As the U.S. Food and Drug Administration undergoes the User Fee Act reauthorization process and renegotiates its user fee agreements over the next several months, the agency's consultation meetings with relevant industries can shed light on the FDA's priorities, and provides stakeholders an opportunity to participate in the reform process, say attorneys at Holland & Knight.
-
Changes Coming To The SBIR And STTR Programs
Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.
-
FDA Framework For Personalized Therapies Raises Questions
The U.S. Food and Drug Administration's new plausible mechanism framework for developing individualized therapies reflects the agency's focus on rare-disease drugs, but numerous significant, unresolved issues cast uncertainty on how effective the framework will be in practice, say attorneys at Ropes & Gray.
-
5 Tips For Navigating Your Firm's All-Attorney Summit
Excerpt from Practical Guidance
Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.
-
Scrutiny Of Nursing Home Practices Marks Inflection Point
Recent congressional inquiries into UnitedHealth Group's Medicare Advantage-linked nursing home practices raise questions about whether financial metrics are allowed to influence decisions governed by the standard of care, and could implicate duties imposed by federal regulations, state negligence laws and elder abuse statutes, says Lindsey Gale at Rafferty Domnick.
-
Series
Coaching Soccer Makes Me A Better Lawyer
Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.
-
Series
Law School's Missed Lessons: The Human Element
Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.
-
CMS Healthcare Enforcement Initiatives May Cause Disruption
The Centers for Medicare & Medicaid Services' recently announced enforcement actions against healthcare fraud mark a significant escalation, and CMS' prior approach in the hospice sector suggests that even compliant providers and suppliers should brace for impact, say attorneys at Morgan Lewis.
-
How Cos. Should Prepare For NY RAISE Act Compliance
With the New York Responsible AI Safety and Education Act taking effect March 19, state regulators will expect subject artificial intelligence governance policies to understand whether appropriate safeguards and protocols are in place to prevent or mitigate discriminatory or adverse outcomes by frontier models, says Michael Paulino at Gordon Rees.
-
What We Know About DOJ's New FCA Enforcement Priorities
Recent remarks from the leader of the Justice Department’s commercial litigation branch provide key insights on how False Claims Act cases — especially healthcare fraud, trade fraud, antidiscrimination and cybersecurity claims — will be evaluated, prioritized and pursued as heightened enforcement becomes the new normal, say attorneys at Latham.